# Lenalidomide

NDC: 63304-045
Generic name: Lenalidomide
Labeler / Manufacturer: Sun Pharmaceutical Industries, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20230312

FDA application: ANDA211846

## Active ingredients

- LENALIDOMIDE: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63304-045"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63304-045
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=84d9dec7-9250-4dbd-9a0d-23e75f111892